Transcriptional Activity of Glutathione S-Transferase Gene in Cancer Patients
Author Information
Author(s): S. McQuaid, S. McCann, P. Daly, E. Lawlor, P. Humphries
Primary Institution: Department of Genetics, University of Dublin, Trinity College
Hypothesis
What is the transcriptional activity of the GST-i gene in human haematological malignancies?
Conclusion
The study found that while GST-x transcript levels were elevated in many leukemia cases, they significantly decreased during the initial stages of chemotherapy.
Supporting Evidence
- GST-x transcript levels were found to be elevated in most cases of malignancy.
- Systematic studies showed dramatic reductions of GST-x transcript levels during chemotherapy.
- Initial levels of GST-x transcript were evident before treatment but dropped to almost undetectable levels after chemotherapy initiation.
Takeaway
This study looked at how a specific gene related to detoxifying drugs behaves in cancer patients, especially during chemotherapy. It found that the gene's activity drops when treatment starts.
Methodology
Total RNA was isolated from bone marrow and/or peripheral leucocytes, and transcript levels were measured using Northern blot analysis.
Limitations
The study primarily focused on a limited number of leukemia types and may not represent all haematological malignancies.
Participant Demographics
Patients included both males and females with various types of leukaemias and preleukaemias.
Want to read the original?
Access the complete publication on the publisher's website